Home › Funds › BRC Group Holdings, Inc. › TOI

BRC Group Holdings, Inc. position in TOI

STARLING ONCOLOGY INC

BRC Group Holdings, Inc. reported holding 722,381 shares of TOI (STARLING ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$4.6M, representing 2.48% of its reported portfolio and ranking #2 among its reported holdings. BRC Group Holdings, Inc. has disclosed TOI holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)722.38K sh
Reported value held$4.57M
Portfolio Weight2.48%
First reportedQ1 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How BRC Group Holdings, Inc.'s TOI position evolved

BRC Group Holdings, Inc. first disclosed a stake in TOI in Q1 2025 at 150,000 shares (US$171K). The position peaked in Q3 2026 at 722,381 shares, worth US$4.6M. Across 7 filings, BRC Group Holdings, Inc. increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 722,381 shares valued at US$4.6M — a reduction of -20,212 shares quarter over quarter.. Notable position changes include a 208% increase in Q2 2025, a 76% increase in Q3 2025, a 40% increase in Q1 2026.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 150.00K $171.00K New
Q2 2025 462.00K $947.10K Add
Q3 2025 811.55K $2.83M Add
Q4 2025 663.38K $2.36M Reduce
Q1 2026 929.73K $2.85M Add
Q2 2026 742.59K $4.03M Reduce
Q3 2026 722.38K $4.57M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TOI and 13F data

TOI (STARLING ONCOLOGY INC) is a company whose sector is not yet classified in our data. 68 other funds we track also report a position in TOI — the largest reported positions include JOSH ARNOLD INVESTMENT CONSULTANT, LLC (US$13.4M), WEXFORD CAPITAL LP (US$10.8M), FourWorld Capital Management LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TOI

All TOI fund holders →

FAQ

How long has BRC Group Holdings, Inc. held TOI?

BRC Group Holdings, Inc. has disclosed TOI holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is BRC Group Holdings, Inc.'s current position in TOI?

As of Q3 2026, BRC Group Holdings, Inc. holds 722.38K shares of TOI (STARLING ONCOLOGY INC), valued at $4.57M, representing 2.48% of its reported portfolio and ranking #2.

Has BRC Group Holdings, Inc. been buying or selling TOI?

In the latest 13F filing (Q3 2026), BRC Group Holdings, Inc. reduced its position in TOI. The position peaked in Q3 2026 at 722.38K shares.

Which other funds hold TOI?

Other major institutional holders of TOI include JOSH ARNOLD INVESTMENT CONSULTANT, LLC, WEXFORD CAPITAL LP, FourWorld Capital Management LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.